Yahoo Suche Web Suche

Anmelden

Suchergebnisse

  1. Suchergebnisse:

  1. www.antarespharma.comHome :: Antares Pharma

    Home :: Antares Pharma. As of May 24, 2022 Halozyme completed its acquisition of Antares Pharma, Inc., creating a leading drug delivery business with broadly licensable opportunities across the ENHANZE® and Antares’ auto injector technologies.

  2. www.prnewswire.com › news-releases › halozyme-to-acquireHalozyme to Acquire Antares Pharma to Create a Specialty Product...

    13. Apr. 2022 · Antares Pharma, Inc. is a specialty pharmaceutical company focused primarily on the development and commercialization of pharmaceutical products and technologies that address patient needs in...

  3. www.pharmaceutical-technology.com › news › halozyme-acquireHalozyme signs agreement to acquire Antares Pharma for $960m

    14. Apr. 2022 · Halozyme Therapeutics has signed a definitive agreement for the acquisition of all of the outstanding shares of Antares Pharma in a deal valued at nearly $960m or $5.60 for each share, in cash. A speciality pharmaceutical firm, Antares focuses on developing pharmaceutical products and technologies to address patient requirements in ...

  4. www.prnewswire.com › news-releases › halozyme-completesHalozyme Completes Antares Pharma Acquisition - PR Newswire

    24. Mai 2022 · SAN DIEGO, May 24, 2022 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) (" Halozyme ") today announced the successful completion of its acquisition of Antares Pharma, Inc. ("...

  5. www.reuters.com › business › halozyme-buy-antares-pharma-960Halozyme bolsters drug delivery business with $960 mln Antares...

    13. Apr. 2022 · April 13 (Reuters) - Halozyme Therapeutics Inc (HALO.O) is bolstering its drug delivery platform with a $960 million all-cash deal for specialty pharmaceutical company Antares Pharma Inc...

  6. www.wsj.com › articles › halozyme-therapeutics-nears-deal-toHalozyme Therapeutics Agrees to Buy Antares Pharma - WSJ

    13. Apr. 2022 · Photo: Michael Nagle/Bloomberg News. HALO 2.15% Halozyme Therapeutics Inc. HALO 2.15% agreed to a nearly $1 billion deal to buy specialty pharmaceutical company Antares Pharma Inc. in a move that ...

  7. finance.yahoo.com › news › antares-pharma-announces-fdaAntares Pharma Announces FDA Approval Of TLANDO™, an Oral...

    29. März 2022 · EWING, N.J., March 29, 2022 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) (the “Company”), a specialty pharmaceutical company, today announced that the U.S. Food and Drug ...